Latest news

Debiopharm International SA Enters the Field of Antibody-Drug Conjugates Through Acquisition of Phase II Asset from ImmunoGen

BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development

Debiopharm International uses cutting-edge ClinTrial App mobile application from ClinOne in clinical study

Debiopharm International SA Appeals to the Supreme Court regarding Towa Pharmaceutical Co., Ltd. case

Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics

Debiopharm Strategic Fund announces FDA clearance of Portfolio Company Immunexpress’ first Test

Debiopharm International SA Appeals to the Supreme Court regarding Nippon Kayaku Co., Ltd. case

Appel à projets pour la 2ème édition du Challenge Debiopharm Inartis

GenePOC announces product launch in Europe and Middle East